BNKL

COM:BIONIKLABS

BIONIK

  • Stock

USD

Market Cap

12

Beta: -

Volume Today

1K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Mar '16
Mar '17
Mar '18
Mar '19
Mar '20
Mar '21
Mar '22
Mar '23
net income
-13.11K
-
-29.53K
125.25%
1.04M
3,609.04%
-3.94M
479.92%
-14.63M
271.54%
-10.56M
27.82%
-25.02M
136.97%
-13.62M
45.55%
-10.41M
23.59%
-4.95M
52.48%
depreciation and amortization
63.45K
-
629.95K
892.76%
412.93K
34.45%
348.21K
15.67%
380.65K
9.32%
189.73K
50.16%
102.62K
45.91%
63.17K
38.45%
deferred income tax
-7.74M
-
-4.18M
46.06%
-19.69K
99.53%
-19.69K
0%
14.18M
72,126.87%
7.18M
49.37%
stock based compensation
1.50M
-
844.16K
43.57%
1.54M
82.50%
1.35M
12.54%
1.78M
32.23%
819.21K
54.02%
384.37K
53.08%
376.50K
2.04%
change in working capital
-1.50K
-
16.32K
1,188.27%
221.88K
1,259.24%
-553.18K
349.31%
123.13K
122.26%
-1.49M
1,308.36%
-570.88K
61.63%
399.19K
169.93%
140.41K
64.83%
1.01M
621.65%
accounts receivables
-377.41K
-
190.87K
150.57%
-1.29M
776.27%
508.73K
139.41%
395.06K
22.34%
177.06K
55.18%
-178.24K
200.67%
inventory
-39.37K
-
-9.19K
76.65%
-168.24K
1,729.88%
-653.78K
288.60%
332.46K
150.85%
-543.96K
263.62%
78.37K
114.41%
accounts payables
-1.50K
-
16.32K
1,188.27%
112.13K
586.90%
-332.01K
396.10%
-60.10K
81.90%
424.18K
805.81%
-291.76K
168.78%
-407.88K
39.80%
-148.96K
63.48%
262.24K
276.05%
other working capital
109.75K
-
195.61K
78.23%
1.55K
99.21%
-453.03K
29,233.50%
-134.07K
70.41%
79.55K
159.34%
656.26K
724.96%
850.87K
29.65%
other non cash items
177.40K
-
199.72K
12.58%
4.86M
2,332.37%
1.14M
76.61%
176.59K
84.46%
406.38K
130.12%
5.63M
1,286.20%
105.79K
98.12%
net cash provided by operating activities
-14.61K
-
-13.20K
9.62%
-4.75M
35,857.56%
-6.99M
47.27%
-7.71M
10.28%
-9.23M
19.73%
-9.06M
1.83%
-4.62M
48.98%
-4.15M
10.31%
-3.39M
18.32%
investments in property plant and equipment
-42.86K
-
-170.79K
298.46%
-21.57K
87.37%
-101.78K
371.92%
-159.65K
56.85%
-12.50K
-
50.19B
401,480,100%
acquisitions net
-215K
-
purchases of investments
sales maturities of investments
other investing activites
-505.06K
-
-50.19B
-
net cash used for investing activites
-547.92K
-
-170.79K
68.83%
-21.57K
87.37%
-101.78K
371.92%
-159.65K
56.85%
-12.50K
-
-223.69K
1,689.55%
debt repayment
-811.56K
-
-50K
93.84%
-523.83K
947.67%
-2.96M
465.54%
-5.55M
87.34%
-2.05M
63.06%
common stock issued
4.55M
-
common stock repurchased
dividends paid
other financing activites
14.08K
-
12.02K
14.61%
2.32M
-
8.51M
265.92%
9.32M
9.59%
11.57M
24.09%
5.92M
48.79%
5.55M
6.33%
4.10M
26.13%
net cash used provided by financing activities
14.08K
-
12.02K
14.61%
4.55M
37,761.02%
2.32M
48.93%
7.70M
231.02%
9.27M
20.50%
11.05M
19.11%
2.96M
73.18%
5.55M
87.34%
2.05M
63.06%
effect of forex changes on cash
36.33K
-
-7.18K
-
-2.99K
58.44%
net change in cash
-527
-
-1.18K
123.91%
-743.35K
62,895.85%
-4.84M
550.85%
-36.34K
99.25%
-60.53K
66.58%
1.82M
3,111.58%
-1.66M
191.14%
1.38M
183.24%
-1.56M
213.08%
cash at beginning of period
4.95K
-
4.42K
10.65%
6.13M
138,414.43%
5.38M
12.14%
543.65K
89.90%
507.31K
6.68%
446.78K
11.93%
2.27M
408.02%
608.35K
73.20%
1.99M
227.34%
cash at end of period
4.42K
-
3.24K
26.68%
5.38M
165,901.14%
543.65K
89.90%
507.31K
6.68%
446.78K
11.93%
2.27M
408.02%
608.35K
73.20%
1.99M
227.34%
427.38K
78.54%
operating cash flow
-14.61K
-
-13.20K
9.62%
-4.75M
35,857.56%
-6.99M
47.27%
-7.71M
10.28%
-9.23M
19.73%
-9.06M
1.83%
-4.62M
48.98%
-4.15M
10.31%
-3.39M
18.32%
capital expenditure
-42.86K
-
-170.79K
298.46%
-21.57K
87.37%
-101.78K
371.92%
-159.65K
56.85%
-12.50K
-
50.19B
401,480,100%
free cash flow
-14.61K
-
-13.20K
9.62%
-4.79M
36,182.18%
-7.16M
49.52%
-7.73M
7.95%
-9.33M
20.71%
-9.22M
1.19%
-4.62M
49.87%
-4.16M
10.04%
50.18B
1,206,450.53%

All numbers in USD (except ratios and percentages)